Skip to content
Open in App
Sun Pharma logo

Sun Pharma

web2

Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures...

Symbol · SUN
Company profile

About

Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations, and active pharmaceutical ingredients (APIs) in India, the United States, and internationally. The company offers formulations in various therapeutic areas, including neuropsychiatry, cardiology, diabetes, gastroenterology, pain/analgesics, gynecology, ophthalmology, urology, dermatology, respiratory, anti-infectives, oncology, psychiatry, neurology, orthopaedic, nephrology, dental, and nutritionals. It also provides generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; specialty medications; antiretrovirals medications; and over-the-counter products, such as vitamins, analgesics, digestives, and lifestyle. In addition, the company offers generics and APIs for anti-cancers, peptides, steroids, sex hormones, immunosuppressant drugs, and controlled substances. Sun Pharmaceutical Industries Limited was founded in 1983 and is headquartered in Mumbai, India.

Explore by sector

Explore this sector

Market identity

Exchange listings

Listing identities only. Orbitrum does not publish live prices or market performance on this public profile.

Progress

Roadmap

Organon shareholders approve proposed Sun Pharma acquisition

KEY STEP

Sun Pharma announced that Organon stockholders approved the proposals connected with the previously announced merger transaction. The company described the vote as an important milestone toward completion, with the acquisition still subject to remaining customary closing conditions and applicable regulatory approvals.

Roadmap reference
People

Company team

DS

Dilip Shantilal Shanghvi

Executive Chairman of the Board

Company leadership profile.

KW

Kirti Wardhaman Ganorkar

Managing Director

Company leadership profile.

AD

Aalok Dilip Shanghvi

COO, Head of Global Generics R&D, Business Devp., and Whole Time Director

Company leadership profile.

VD

Vidhi Dilip Shanghvi

Whole-Time Director

Company leadership profile.

GB

Gautam Bhailal Doshi

Non-Executive Independent Director

Company leadership profile.

PK

Pawan Kumar Goenka

Lead Independent Director

Company leadership profile.

RK

Rolf Karl-Heinz Hoffmann

Independent Director

Company leadership profile.

SB

Satyavati Berera

Independent Director

Company leadership profile.

AE

Andreas Eugen Busch

Independent Director

Company leadership profile.

Expert coverage

1 expert evaluated Sun Pharma.

Orbitrum research

Experts evaluating Sun Pharma

Explore the public profiles of experts who have evaluated this project.

Orbitrum Academy

Learn how to read a project assessment